Why is Godavari Drugs falling/rising?

As of 12-Sep, Godavari Drugs Ltd's stock price is currently at Rs 82.28, reflecting an increase of Rs 0.85 or 1.04%. Despite this uptick, the stock has shown a negative performance over various time frames, including a decline of 4.89% over the past month and a significant drop of 40.09% over the last year. The stock is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, while the stock has outperformed its sector by 0.68% today, it is still close to its 52-week low, being just 3.92% away from Rs 79. The company has reported a very attractive valuation with a return on capital employed (ROCE) of 11.7, but it has also faced challenges, including a 41.2% decline in profits over the past year and negative results for the last three consecutive quarters. In the broader market context, the Sensex has increased by 1.48% over the past week, contrasting with Godavari Drugs' decline of 0.25% during the same period. This underperformance highlights the stock's struggle to keep pace with the overall market. The company's weak long-term fundamentals, characterized by a high debt-to-EBITDA ratio of 3.27 times and a compound annual growth rate (CAGR) of only 9.87% in operating profits over the last five years, further contribute to investor skepticism. Despite a rise in investor participation, as evidenced by a 33.19% increase in delivery volume, the overall sentiment remains cautious due to the stock's historical underperformance against benchmarks and its recent financial difficulties.